-
Genetic landscape of pediatric ependymoma
Study
EGAS00001000254
-
Genetic landscape of pediatric Rhabdomyosarcoma
Study
EGAS00001000256
-
Whole genome and RNA sequencing of paediatric glioblastoma in the ICGC PedBrain project
Study
EGAS00001001139
-
560 whole-genome sequenced breast cancers
Study
EGAS00001001178
-
Comprehensive molecular profiling identifies novel genetic drivers and subtypes underlying medulloblastoma
Study
EGAS00001001953
-
Resolving the immune landscape of human prostate at a single cell level in health and cancer
Study
EGAS00001005787
-
Cell_lines_with_telomere_fusion_induced_rearrangements
Study
EGAS00001001059
-
Osteosarcoma_Whole_Genome
Study
EGAS00001000147
-
Submission 45 - study_title 1
Study
EGAS50000000494
-
CRUK-ICGC Prostate Cancer Group Study
Study
EGAS00001000262
-
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
Study
EGAS00001000566
-
Metastatic_Prostate_Follow_Up
Study
EGAS00001000730
-
Metastatic_Prostate_Follow_Up_2
Study
EGAS00001000756
-
Distinct evolutionary trajectories of primary high grade serous ovarian cancers revealed through spatial mutational profiling
Study
EGAS00001000547
-
The BC Cancer Agency's Personalized Onco-Genomics Project
Study
EGAS00001001159
-
Sequencing of an organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.
Study
EGAS00001003853
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
Fasting-mimicking diet reshapes antitumor immunity in cancer patients
Study
EGAS00001004944
-
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in HGSOC
Study
EGAS00001006807
-
Identification of novel colorectal cancer predisposition genes
Study
EGAS00001005118
-
PanCuRx Translational Research Initiative
Study
EGAS00001002543
-
Exploration_of__mutational_processes_in_human_cancer_cell_lines__Exome
Study
EGAS00001000790
-
Scottish High Grade Serous Ovarian Cancer
Study
EGAS00001004410
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
A renal cell carcinoma tumorgraft platform to advance precision medicine
Study
EGAS00001005516
-
Prostate cancer ancestral genomic disparity
Study
EGAS00001006425
-
RNA Editing in breast cancer
Study
EGAS00001000495
-
Allele-specific expression of GATA2 due to epigenetic dysregulation in double mutated CEBPA AML
Study
EGAS00001004684
-
Single cell RNA sequencing of colorectal cancer patients (KUL3/KUL5)
Study
EGAS00001006049
-
Submission 16 - study_title 2
Study
EGAS50000000503
-
DNA-methylation variability in normal mucosa of patients with adenomatous polyps: a marker of field cancerization
Study
EGAS00001007666
-
RNA-seq of Glioblastoma stem cells
Study
EGAS00001003070
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
High-grade serous ovarian cancer refined with single-cell RNA-sequencing
Study
EGAS00001004987
-
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Study
EGAS00001005013
-
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
Study
EGAS00001005115
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Genome Landscape of High-Grade Serous Ovarian Cancer
Study
EGAS00001000397
-
Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer
Study
EGAS00001004219
-
Homologous recombination DNA repair deficiency and activity of PARP inhibition in primary triple negative breast cancer
Study
EGAS00001004190
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Study
EGAS00001002556
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
National Human Genome Research Institute Tumor Sequencing Project (TSP) - Lung Adenocarcinoma
Study
phs000144
-
Study of Addiction: Genetics and Environment (SAGE)
Study
phs000092
-
A Genome Wide Scan of Lung Cancer and Smoking
Study
phs000093
-
Whole Genome Association Study of Systemic Lupus Erythematosus
Study
phs000122
-
Neuroblastoma Genome-Wide Association Study (NBL-GWAS)
Study
phs000124
-
Cancer Genetic Markers of Susceptibility (CGEMS) Breast Cancer Genome-wide Association Study (GWAS) - Primary Scan: Nurses' Health Study - Additional Cases: Nurses' Health Study 2
Study
phs000147
-
National Institutes of Health The Cancer Genome Atlas (TCGA)
Study
phs000178
-
High Density SNP Association Analysis of Melanoma: Case-Control and Outcomes Investigation
Study
phs000187
-
Women's Health Initiative Clinical Trial and Observational Study
Study
phs000200
-
International Standards for Cytogenomic Arrays
Study
phs000205
-
Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case-Control Consortium (PanScan)
Study
phs000206
-
Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer Genome-Wide Association Study (GWAS) - Primary Scan (Stage 1) - PLCO Screening Trial
Study
phs000207
-
A Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on NCIC CTG Trial MA.27 Evaluating Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine.
Study
phs000210
-
National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments
Study
phs000218
-
Population Architecture using Genomics and Epidemiology (PAGE): Multiethnic Cohort (MEC)
Study
phs000220
-
Development and Use of Network Infrastructure for High-Throughput GWA Studies
Study
phs000234
-
National Cancer Institute Cancer Genome Characterization Initiative (CGCI)
Study
phs000235
-
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Study
phs000239
-
Whole Genome Sequencing of a Triple Negative Breast Cancer Patient: Matched Primary Tumor, Normal, Metastasis and Xenograft samples
Study
phs000245
-
Genetic Determinants of Viral Clearance in HCV-Infected Populations
Study
phs000248
-
CALGB 80303:Genome-Wide Association Study of Advanced Pancreatic Cancer Patients - A Randomized Phase III trial of Gemcitabine Plus Bevacizumab versus Gemcitabine Plus Placebo in Patients with Advanced Pancreatic Cancer
Study
phs000250
-
National Human Genome Research Institute (NHGRI) GENEVA Genome-Wide Association Study of Venous Thrombosis (GWAS of VTE)
Study
phs000289
-
Whole genome and transcriptome sequencing of lung cancer patients and cell lines at Genentech
Study
phs000299
-
A Genome-Wide Association Study in Participants Experiencing Breast Cancer Events in High-Risk Postmenopausal Women Receiving Selective Estrogen Receptor Modulators on NSABP Trials P-1 and P-2. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine
Study
phs000305
-
A Multiethnic Genome-wide Scan of Prostate Cancer
Study
phs000306
-
Discovery of Non-ETS Gene Fusions in Human Prostate Cancer using Next Generation RNA Sequencing
Study
phs000310
-
FusionSeq: a modular framework for finding gene fusions by analyzing Paired-End RNA-Sequencing data
Study
phs000311
-
The Genomic Complexity of Primary Human Prostate Cancer
Study
phs000330